September 25, 2024Open Access
Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder
Key Points
Key points are not available for this paper at this time.
Abstract
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
W
William Yang Wang
Hong Kong Polytechnic University
Nora D. Volkow
Northwestern University
Q
QuangQiu Wang
Case Western Reserve University
Journals
JAMA Network Open
Actions
Institutions
National Institutes of Health
Case Western Reserve University
University School
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...